A big project milestone has been reached as the last few patients have been randomized. Thanks to the last achievements and efforts made by the PIs to recruit patients, the DEEP-2 Study has finally completed the enrollment.
The last patients were included in Albania, Italy and UK while the 393rd patient has been randomized on 14/7/2016 in UK.
An important action carried out by the DEEP-2 Trial Management Team aimed at ensuring the correct implementation of the study protocol is the release of a monthly DEEP-2 study newsletter (available on the DEEP website in the Study Newsletter section), that is sent to all PIs and also available on the website, aimed at clarifying most of the criticisms of the study protocol.
Stay connected with the DEEP website and social networks (Facebook and Google+) to be updated.
